ZA955896B - Technetium-sulfonamide complexes their use pharmaceutical agents containing the latter as well as process for the production of the complexes and agents - Google Patents

Technetium-sulfonamide complexes their use pharmaceutical agents containing the latter as well as process for the production of the complexes and agents

Info

Publication number
ZA955896B
ZA955896B ZA955896A ZA955896A ZA955896B ZA 955896 B ZA955896 B ZA 955896B ZA 955896 A ZA955896 A ZA 955896A ZA 955896 A ZA955896 A ZA 955896A ZA 955896 B ZA955896 B ZA 955896B
Authority
ZA
South Africa
Prior art keywords
complexes
technetium
sulfonamide
agents
production
Prior art date
Application number
ZA955896A
Inventor
Johannes Platzek
Wolfgang Kramp
Bernd Raduechel
Ludger Dinkelborg
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA955896B publication Critical patent/ZA955896B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/20Esters of monothiocarboxylic acids
    • C07C327/32Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/16Isothiocyanates
    • C07C331/28Isothiocyanates having isothiocyanate groups bound to carbon atoms of six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005Compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA955896A 1994-07-14 1995-07-14 Technetium-sulfonamide complexes their use pharmaceutical agents containing the latter as well as process for the production of the complexes and agents ZA955896B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4425781A DE4425781A1 (en) 1994-07-14 1994-07-14 Technetium sulfonamide complexes, their use, pharmaceutical compositions containing them, and processes for the preparation of the complexes and compositions

Publications (1)

Publication Number Publication Date
ZA955896B true ZA955896B (en) 1996-02-19

Family

ID=6523740

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA955896A ZA955896B (en) 1994-07-14 1995-07-14 Technetium-sulfonamide complexes their use pharmaceutical agents containing the latter as well as process for the production of the complexes and agents

Country Status (11)

Country Link
EP (1) EP0770063A1 (en)
JP (1) JPH10502648A (en)
KR (1) KR970704682A (en)
CN (1) CN1152914A (en)
AU (1) AU698824B2 (en)
CA (1) CA2194561A1 (en)
DE (1) DE4425781A1 (en)
HU (1) HUT76806A (en)
NO (1) NO970140L (en)
WO (1) WO1996002500A1 (en)
ZA (1) ZA955896B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028422A (en) * 1986-05-27 1991-07-02 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
AU2001278188B2 (en) * 2000-07-06 2007-05-17 Amgen Inc. Tyrosine derivatives as phosphatase inhibitors
KR100445971B1 (en) * 2002-04-15 2004-08-25 한국원자력연구소 Process for labeling technetium or rhenium using borohydride exchange resin
EP1501551B1 (en) * 2002-05-06 2009-11-18 Endocyte, Inc. Folate-receptor targeted imaging agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980147A (en) * 1984-06-25 1990-12-25 University Of Utah Research Foundation Radiolabeled technetium chelates for use in renal function determinations
ATE52516T1 (en) * 1986-05-28 1990-05-15 Mallinckrodt Inc TECHNETIUM CHELATE FOR DETERMINING KIDNEY FUNCTION.

Also Published As

Publication number Publication date
AU2886595A (en) 1996-02-16
NO970140D0 (en) 1997-01-13
AU698824B2 (en) 1998-11-05
DE4425781A1 (en) 1996-01-18
CN1152914A (en) 1997-06-25
HUT76806A (en) 1997-11-28
KR970704682A (en) 1997-09-06
JPH10502648A (en) 1998-03-10
WO1996002500A1 (en) 1996-02-01
CA2194561A1 (en) 1996-02-01
EP0770063A1 (en) 1997-05-02
NO970140L (en) 1997-03-13

Similar Documents

Publication Publication Date Title
HUT76286A (en) Quinoline derivatives, pharmaceutical compositions containing them, process for producing them and their use
HU895595D0 (en) Diagnostical preparations and process for the production of chelates
HU913448D0 (en) 1-(2-arylethyl)-pyrrholidines and process for their production and the medical preparations containing them
HU913583D0 (en) Process for the production of substituted azoles and of medical preparations containing them
IL124768A0 (en) Novel pyridine compounds processes for their preparation and their use as pharmaceutical agents
HU911443D0 (en) Process for the production of medical preparations containing pravastaine and fibrinous-acid derivatives
HUT64180A (en) Process for producing new pirazole derivatives and fungicidal compositions containing said derivatives
ZA941522B (en) New 4-aminopyridines - processes for their production as well as pharmaceutical agents containing them
HUT46644A (en) Process for producing propylophenone derivatives and pharmaceutical compositions comprising the same
HUT53877A (en) Fungicidal preparations containing 2-anilinocianopyridines as agents and process for producing the agent
HU9102385D0 (en) Process for the production of medical preparations
ZA949604B (en) Haloaryl-substituted metal complexes pharmaceutical agents containing these complexes, their use in diagnosis, as well as process for the production of the complexes and agents
HUT65768A (en) 17-beta-substituted 4-aza-androstane-derivatives and pharmaceutical compositions containing them and process for the production thereof
ZA955896B (en) Technetium-sulfonamide complexes their use pharmaceutical agents containing the latter as well as process for the production of the complexes and agents
HU912517D0 (en) New 1-diphenyl-methyl-piperazine derivatives, process for their production, and for the production of medical preparations containing thereof
HU9402535D0 (en) Process for producing vinpocetine complexes and pharmaceutical compositions containing them
HU913654D0 (en) Process for the production of new amino-diol-derivatives and medical preparations containing them
EP0486946A3 (en) Process for the production of metallopolysilanes and their use
HU911086D0 (en) Process for the production and use of 2-dezoxy-d-treo-pentofluoranozides and intermediers thereof
EP0698598A3 (en) Process for the preparation of amides
GR3036226T3 (en) 6-methoxy-1h-benzotriazole-5-carboxamide derivatives, process for producing the same, and medicinal composition containing the same
HUT64757A (en) Process for the production of n-tetrahydrofuryl-piperidine-derivatives and of medical preparatives containing them
ZA955895B (en) Conjugates made of metal complexes and oligonucleotides agents containing the conjugates their use in radiodiagnosis as well as process for their production
HU9200294D0 (en) Process for the production of medical preparations
HUT69382A (en) 7-azabicyclo [2.2.1]heptane derivatives and pharmaceutical compositions containing the same and process for the production thereof